According to Wang et al. (2017), sodium butyrate, an SCFA, lowers blood pressure through the renin-angiotensin system pathway, especially by inhibiting the intrarenal renin-angiotensin system which raises blood pressure in angiotensin II-induced hypertension. The gene discussed is REN; the disease is hypertensive disorder.